InvestorsHub Logo
Followers 40
Posts 7682
Boards Moderated 1
Alias Born 01/04/2006

Re: None

Wednesday, 12/18/2013 10:31:26 PM

Wednesday, December 18, 2013 10:31:26 PM

Post# of 3140
ONTX $13.32
4:45 pm Onconova Therapeutics announces discontinuation of the Phase 3 ONTRAC study of intravenous rigosertib plus gemcitabine in front-line metastatic pancreatic cancerBriefing.com(Wed 3:09AM EST)
Onconova Announces Results of Interim Analysis of Metastatic Pancreatic Cancer StudyGlobeNewswire(Tue, Dec 17)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONTX News